Figure 5.

Survival in all patients in the database in whom lymph node status is known. Survival is inferior in node-positive patients and in patients who are expressors (MAPS+). MAPS adds significantly to prognostication in both node-negative and node-positive patients.

MacDermed et al. BMC Medical Genomics 2010 3:16   doi:10.1186/1755-8794-3-16
Download authors' original image